Eucure Biopharma

Eucure Biopharma is a biotechnology company based in Beijing, China, specializing in the discovery and development of innovative immuno-oncology targeted antibodies. The company's primary focus is on immune checkpoints, with several products having advanced to the Chemistry, Manufacturing, and Controls (CMC) stage and clinical trials initiated in 2019. Eucure Biopharma aims to create antibody treatments that enhance the survival rates of patients with tumors, offering healthcare professionals more effective options for cancer treatment through the development of checkpoint and cancer growth inhibitors.